Anti-CD20 in SLE (AC002)
收藏DataCite Commons2022-12-21 更新2025-04-16 收录
下载链接：
https://www.immport.org/shared/study/SDY625
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the safety and effectiveness of rituximab (anti-CD20) in treating systemic lupus erythematosus (SLE). White blood cells in the body called B cells give off substances that are active in promoting SLE disease. Researchers have found that anti-CD20 can block production of these substances in another disease. This study explores whether anti-CD20 will also be safe in people with SLE and whether it may be effective in treating SLE.
提供机构：
ImmPort
创建时间：
2017-06-08
